VTA-420

N/A

Report date: 2025/04/21 11:21:40

Base Information

Drug NameVTA-420

Drug Alias NameVTA-420

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapyCell and gene therapy > Gene therapy > Gene editing > CRISPR

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVita Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesVita Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A